How Haya Therapeutics is targeting the dark genome to treat fibrotic disease
AT A GLANCE Publicly launched: 2021 Headquarters: Lausanne, Switzerland, and San Diego Focus: Precision RNA-guided therapeutics targeting…
Browsing Tag
lncrna
1 post